Home » Newsletters » BioWorld Science

BioWorld Science

June 25, 2014

View Archived Issues

Celsion completes acquisition of EGEN

Merck KGaA to begin phase I trial of MSB-0010841 in patients with psoriasis

Orexo reports phase III data on Zubsolv for induction of buprenorphine maintenance therapy

Scripps Research Institute and T23 sign license for CD22 siglec oncoimmunological platform

Inovio's INO-3112 enters phase I/IIa trial in cervical cancer

Ultra-long-acting LAPS-insulin well tolerated and active in type 1 and 2 diabetes

Phase II results reported for indisulam with idarubicin and cytarabine in myeloid malignancies

Results of phase I trial: pevonedistat in combination with azacitidine for AML

Dose-escalation study of mPEG-r-crisantaspase, a new PEGylated asparaginase

Phase I and expansion cohort results presented for a yeast-based therapeutic cancer vaccine

EDO-S101, a novel candidate for the treatment of multiple myeloma

Verona Pharma's VRP-700 misses endpoint in chronic cough trial

Bayer HealthCare and Dimension Therapeutics to develop novel gene therapy for hemophilia A

Living Cell Technologies resumes trial of encapsulated cell therapy in Parkinson's disease

XenoPort begins phase II trial of XP-23829 in patients with psoriasis

Genocea reports topline phase I data for universal pneumococcus vaccine candidate

EMA's COMP adopts positive opinion on marizomib in multiple myeloma

Akorn sells subsidiary to Valeant Pharmaceuticals

Trevena reports phase I results for TRV-734 in acute and chronic pain

Hangzhou Zylox Pharma discloses new rapamycin analogues

Boehringer Ingelheim decides not to pursue hepatitis C drug development

NovoMedix patents novel treatments for cancer and fibrosis

Kyowa Hakko Kirin patent reports new CCR10 receptor antagonists

Allergan board of directors rejects exchange offer from Valeant Pharmaceuticals

Scientists at Temple University prepare and test novel 5-HT2B antagonists

Sunovion Pharmaceuticals reports development of PDE10A inhibitors

Roche files IND to begin phase II study of Erivedge in IPF

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...